UK markets closed

GlaxoSmithKline plc (GSK.L)

LSE - LSE Delayed price. Currency in GBp
Add to watchlist
1,291.80-12.40 (-0.95%)
At close: 4:38PM GMT

GlaxoSmithKline plc

980 Great West Road
Brentford TW8 9GS
United Kingdom
44 20 8047 5000
http://www.gsk.com

Sector(s)Healthcare
IndustryDrug Manufacturers—General
Full-time employees99,437

Key executives

NameTitlePayExercisedYear born
Ms. Emma N. WalmsleyCEO & Director3.29M1.6M1970
Mr. Iain James MackayCFO & Exec. Director2.36MN/A1962
Dr. Hal V. BarronChief Scientific Officer, Pres of R&D and Director6.34MN/A1963
Ms. Karenann K. TerrellChief Digital & Technology OfficerN/AN/A1961
Ms. Sarah Elton-FarrHead of Investor RelationsN/AN/AN/A
Mr. Nick HironsSr. VP of Global Ethics & ComplianceN/AN/AN/A
Mr. James FordSr. VP & Gen. CounselN/AN/AN/A
Ms. Sally JacksonSr. VP of Global Communications & CEO OfficeN/AN/AN/A
Ms. Diana ConradSr. VP of HRN/AN/AN/A
Mr. David Simon RedfernChief Strategy OfficerN/AN/A1966
Amounts are as of 31 December 2019, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in GBp.

Description

GlaxoSmithKline plc engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as respiratory, HIV, immuno-inflammation, oncology, anti-viral, central nervous system, cardiovascular and urogenital, metabolic, anti-bacterial, and dermatology. It also provides consumer healthcare products in wellness, oral health, nutrition, and skin health categories. The company offers its consumer healthcare products in the form of nasal sprays, tablets, syrups, lozenges, gum and trans-dermal patches, caplets, infant syrup drops, liquid filled suspension, wipes, gels, effervescents, toothpastes, toothbrushes, mouthwashes, denture adhesives and cleansers, topical creams and non-medicated patches, lip balm, gummies, and soft chews. It has collaboration agreements with 23andMe; Merck KGaA; Lyell Immunopharma; CEPI; Innovax and Xiamen University; VBI; Viome; Sanofi SA; CureVac; and research collaboration with Sengenics focusing on immunology. GlaxoSmithKline plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.

Corporate governance

GlaxoSmithKline plc’s ISS governance QualityScore as of 31 October 2019 is 7. The pillar scores are Audit: 1; Board: 5; Shareholder rights: 1; Compensation: 8.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.